
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Coronary heart disease secondary prevention cardiac rehabilitation
Introduction
2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease (DO NOT EDIT) [1]
2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease (DO NOT EDIT) [1]
Cardiac Rehabilitation (DO NOT EDIT) [1]
| Class I |
| “1. All eligible patients with ACS or whose status is immediately post coronary artery bypass surgery or post-PCI should be referred to a comprehensive outpatient cardiovascular rehabilitation program either prior to hospital discharge or during the first follow-up office visit. [2][3][4][5] (Level of Evidence: A) ” |
| “2. All eligible outpatients with the diagnosis of ACS, coronary artery bypass surgery or PCI (Level of Evidence: A) [2][3][6][4], chronic angina (Level of Evidence: B) [4][5] and/or peripheral artery disease (Level of Evidence: A) [7][8] within the past year should be referred to a comprehensive outpatient cardiovascular rehabilitation program. ” |
| “3. A home-based cardiac rehabilitation program can be substituted for a supervised, center-based program for low-risk patients. [9][10] (Level of Evidence: A) ” |
| Class IIa |
| “1. A comprehensive exercise-based outpatient cardiac rehabilitation program can be safe and beneficial for clinically stable outpatients with a history of heart failure. [11][12][13][14] (Level of Evidence: B) ” |
References
References
- ↑ 1.0 1.1 Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA; et al. (2011). “AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation”. Circulation. 124 (22): 2458–73. doi:10.1161/CIR.0b013e318235eb4d. PMID 22052934.
- ↑ 2.0 2.1 Taylor RS, Brown A, Ebrahim S; et al. (2004). “Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials”. Am. J. Med. 116 (10): 682–92. doi:10.1016/j.amjmed.2004.01.009. PMID 15121495. Unknown parameter
|month=ignored (help) - ↑ 3.0 3.1 Clark AM, Hartling L, Vandermeer B, McAlister FA (2005). “Meta-analysis: secondary prevention programs for patients with coronary artery disease”. Ann. Intern. Med. 143 (9): 659–72. PMID 16263889. Unknown parameter
|month=ignored (help) - ↑ 4.0 4.1 4.2 Thomas RJ, King M, Lui K, Oldridge N, Piña IL, Spertus J (2007). “AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services”. Circulation. 116 (14): 1611–42. doi:10.1161/CIRCULATIONAHA.107.185734. PMID 17885210. Unknown parameter
|month=ignored (help) - ↑ 5.0 5.1 Walther C, Möbius-Winkler S, Linke A; et al. (2008). “Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease”. Eur J Cardiovasc Prev Rehabil. 15 (1): 107–12. doi:10.1097/HJR.0b013e3282f29aa6. PMID 18277195. Unknown parameter
|month=ignored (help) - ↑ Hambrecht R, Walther C, Möbius-Winkler S; et al. (2004). “Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial”. Circulation. 109 (11): 1371–8. doi:10.1161/01.CIR.0000121360.31954.1F. PMID 15007010. Unknown parameter
|month=ignored (help) - ↑ McDermott MM, Ades P, Guralnik JM; et al. (2009). “Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial”. JAMA. 301 (2): 165–74. doi:10.1001/jama.2008.962. PMC 3268032. PMID 19141764. Unknown parameter
|month=ignored (help) - ↑ Watson L, Ellis B, Leng GC (2008). “Exercise for intermittent claudication”. Cochrane Database Syst Rev (4): CD000990. doi:10.1002/14651858.CD000990.pub2. PMID 18843614.
- ↑ Taylor RS, Dalal H, Jolly K, Moxham T, Zawada A (2010). “Home-based versus centre-based cardiac rehabilitation”. Cochrane Database Syst Rev (1): CD007130. doi:10.1002/14651858.CD007130.pub2. PMID 20091618.
- ↑ Clark AM, Haykowsky M, Kryworuchko J; et al. (2010). “A meta-analysis of randomized control trials of home-based secondary prevention programs for coronary artery disease”. Eur J Cardiovasc Prev Rehabil. 17 (3): 261–70. PMID 20560165. Unknown parameter
|month=ignored (help) - ↑ O’Connor CM, Whellan DJ, Lee KL; et al. (2009). “Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial”. JAMA. 301 (14): 1439–50. doi:10.1001/jama.2009.454. PMC 2916661. PMID 19351941. Unknown parameter
|month=ignored (help) - ↑ Belardinelli R, Georgiou D, Cianci G, Purcaro A (1999). “Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome”. Circulation. 99 (9): 1173–82. PMID 10069785. Unknown parameter
|month=ignored (help) - ↑ Piepoli MF, Davos C, Francis DP, Coats AJ (2004). “Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)”. BMJ. 328 (7433): 189. doi:10.1136/bmj.37938.645220.EE. PMC 318480. PMID 14729656. Unknown parameter
|month=ignored (help) - ↑ Passino C, Severino S, Poletti R; et al. (2006). “Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure”. J. Am. Coll. Cardiol. 47 (9): 1835–9. doi:10.1016/j.jacc.2005.12.050. PMID 16682309. Unknown parameter
|month=ignored (help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
